686 results on '"Kubo, Toru"'
Search Results
202. A case of percutaneous transluminal renal angioplasty for partial coverage of a renal artery by a stent graft after endovascular aneurysm repair
203. プラトンのエロース論
204. Multiple coronary artery–left ventricle microfistulae
205. Gender Differences in the Clinical Features of Hypertrophic Cardiomyopathy Caused by Cardiac Myosin-binding Protein C Gene Mutations
206. Influences of Donepezil on Cardiovascular System—Possible Therapeutic Benefits for Heart Failure—DOnepezil Cardiac TEst Registry (DOCTER) Study
207. Complex venous malformation in an elderly female: A case report
208. Usefulness of High-Sensitive Cardiac Troponin T for Evaluating the Activity of Cardiac Sarcoidosis
209. Ruptured adult umbilical hernia caused by intractable ascites associated with liver cirrhosis
210. Combined Measurements of Cardiac Troponin I and Brain Natriuretic Peptide Are Useful for Predicting Adverse Outcomes in Hypertrophic Cardiomyopathy
211. Genetic Screening and Double Mutation in Japanese Patients With Hypertrophic Cardiomyopathy
212. Turbulent left-to-right shunt flow through the interatrial septum suggesting high left atrial pressure in patients with heart failure with preserved ejection fraction
213. 201-Thallium SPECT Could Predict the Prognosis of Dilated Phase of Hypertrophic Cardiomyopathy
214. Inflammatory Abdominal Aortic Aneurysm Successfully Treated With Steroid Therapy
215. Clinical Features of the Dilated Phase of Hypertrophic Cardiomyopathy in Comparison With Those of Dilated Cardiomyopathy
216. Development of a Reverse Transcription-Loop-Mediated Isothermal Amplification Assay for Detection of Pandemic (H1N1) 2009 Virus as a Novel Molecular Method for Diagnosis of Pandemic Influenza in Resource-Limited Settings
217. Impact of Metalloproteinases on Left Ventricular Remodeling and Heart Failure Events in Patients With Hypertrophic Cardiomyopathy
218. Plasma Adiponectin Levels and Left Ventricular Remodeling in Hypertrophic Cardiomyopathy
219. Serum Cardiac Troponin I is Related to Increased Left Ventricular Wall Thickness, Left Ventricular Dysfunction, and Male Gender in Hypertrophic Cardiomyopathy
220. Gender Differences in the Clinical Features of Hypertrophic Cardiomyopathy in an Unselected Regional Japanese Population
221. Left Ventricular Reverse Remodeling After Beta-blocker Therapy in Dilated Cardiomyopathy: Is it Maintained at Long-term Follow-up?
222. Cardiac Ankyrin Repeat Protein Gene (ANKRD1) Mutations in Hypertrophic Cardiomyopathy
223. P-22 Electrocardiographic Pattern of Giant Negative T Wave: Is It a Benign Prognostic Sign in Hypertrophic Cardiomyopathy?
224. S7-2 Multi-Biomarkers and Left Ventricular Remodeling in Hypertrophic Cardiomyopathy
225. P-21 CArdiac Troponin I Is Related to Maximum LV Wall Thickness, LV Dysfunction and Male Gender in Hypertrophic Cardiomyopathy
226. P-20 Impact of Atrial Fibrillation in Elderly Patients with Hypertrophic Cardiomyopathy: Results from Kochi Cardiomyopathy Network
227. A 77-year-old Woman Presenting Breathlessness and Edema
228. Clinical Impact of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy Results From Kochi RYOMA Study
229. Clinical Profiles of Hypertrophic Cardiomyopathy With Apical Phenotype Comparison of Pure-Apical Form and Distal-Dominant Form
230. This title is unavailable for guests, please login to see more information.
231. Interaction of BMP10 with Tcap may modulate the course of hypertensive cardiac hypertrophy
232. Risk Factors for Heart Failure in Patients with Atrial Fibrillation Without Underlying Heart Disease: Gender Difference
233. A novel method for rapid detection of Streptococcus pneumoniae antigens in blood.
234. Erythrocyte creatine as a marker of intravascular hemolysis due to left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
235. Prevalence, Clinical Significance, and Genetic Basis of Hypertrophic Cardiomyopathy With Restrictive Phenotype
236. Metastatic cardiac tumor from urothelial carcinoma detected by transthoracic echocardiography: a case report.
237. Germline mutations causing familial lung cancer.
238. Gender differences in the clinical features of hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.
239. Renal Insufficiency: A Risk Factor for Heart Failure in Patients with Atrial Fibrillation Without Underlying Heart Disease
240. Quantitative analysis of carotid atherosclerotic lesions and high‐sensitivity C‐reactive protein in community‐dwelling elderly 80 years or older
241. Morphologic Characteristics of Hypertrophic Cardiomyopathy of the Elderly With Cardiac Myosin-Binding Protein C Gene Mutations
242. Long-Term Prognosis of Dilated Cardiomyopathy Revisited An Improvement in Survival Over the Past 20 Years
243. Left Ventricular Remodeling of Hypertrophic Cardiomyopathy Longitudinal Observation in a Rural Community
244. Lifelong Left Ventricular Remodeling of Hypertrophic Cardiomyopathy Caused by a Frameshift Deletion Mutation in the Cardiac Myosin-binding Protein C Gene
245. Heart Failure and In-hospital Mortality in Patients with Acute Myocardial Infarction: Impact of Coronary Intervention (Kochi Acute Myocardial Infarction Registry)
246. Lifelong Left Ventricular Remodeling of Hypertrophic Cardiomyopathy Caused by a Founder Frameshift Deletion Mutation in the Cardiac Myosin-Binding Protein C Gene Among Japanese
247. Functional Assessment by Myocardial Performance Index (Tei Index) Correlates With Plasma Brain Natriuretic Peptide Concentration in Patients With Hypertrophic Cardiomyopathy
248. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy
249. The Puzzle of Likeness Regress : Parmenides 132c-133a
250. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.